PTEN Promoter Methylation in Sporadic Thyroid Carcinomas

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Thyroid

• Publication date

  2006-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/thy.2006.16.17PMID 16487009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTEN methylation and expression in glioblastomas

  2003cited by this paper
• PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome.

  2002cited by this paper
• Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis

  2002cited by this paper
• Considerations when analyzing the methylation status of PTEN tumor suppressor gene.

  2002cited by this paper
• Aberrant DNA methylation in cancer: potential clinical interventions

  2002cited by this paper
• Molecular pathobiology of thyroid neoplasms

  2002cited by this paper
• PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.

  2002cited by this paper
• Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

  2002cited by this paper
• Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.

  2001cited by this paper
• Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.

  2001cited by this paper
• Thyroid cancer.

  2001cited by this paper
• Molecular pathology of endometrial hyperplasia and carcinoma.

  2001cited by this paper
• An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice

  2001cited by this paper
• PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma

  2001cited by this paper
• PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1

  2000cited by this paper
• Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.

  2000cited by this paper
• Expression of the PTEN tumour suppressor protein during human development.

  2000cited by this paper
• PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.

  2000cited by this paper
• Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.

  2000cited by this paper
• Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.

  2000cited by this paper
• PTEN: a tumour suppressor that functions as a phospholipid phosphatase.

  1999cited by this paper
• Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

  1999cited by this paper
• Fine‐structure deletion mapping of 10q22–24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways

  1999cited by this paper
• Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.

  1999cited by this paper
• Down-regulation of Human DNA-(Cytosine-5) Methyltransferase Induces Cell Cycle Regulators p16 ink4A and p21WAF/Cip1 by Distinct Mechanisms*

  1999cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.

  1999cited by this paper
• Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN

  1999cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors

  1998cited by this paper
• Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.

  1998influential reference
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.

  1997cited by this paper
• Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

  1997cited by this paper
• Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

  1997cited by this paper
• Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

  1997cited by this paper
• New Tumor Suppressor Found--Twice

  1997cited by this paper
• PTEN/MMAC1 mutations in endometrial cancers.

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997influential reference
• The relationship of DNA methylation to cancer.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.

  1995cited by this paper
• [Thyroid cancer].

  1951cited by this paper

• The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis

  2025cites this paper
• Environmental Exposure to Bisphenol A Enhances Invasiveness in Papillary Thyroid Cancer

  2025cites this paper
• Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to “double invasion”: an analytical approach utilizing lasso-cox regression

  2025cites this paper
• Epigenetic control in thyroid cancer: mechanisms and clinical perspective

  2025cites this paper
• Molecular Mechanisms of Thyroid Hormone Signaling in Thyroid Cancer: Oncogenesis, Progression, and Therapeutic Implications

  2025cites this paper
• Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma

  2024cites this paper
• Analytical and therapeutic profiles of DNA methylation alterations in cancer; an overview of changes in chromatin arrangement and alterations in histone surfaces

  2023cites this paper
• Liquid Biopsy as a Method for Minimally Invasive Diagnosis of Thyroid Cancer

  2023cites this paper
• Stress, Thyroid Dysregulation, and Thyroid Cancer in Children and Adolescents: Proposed Impending Mechanisms

  2022cites this paper
• Biomarkers in Endocrine Organ Carcinomas

  2022cites this paper
• Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma

  2022cites this paper
• The Role of DNA Methylation and DNA Methyltransferases in Cancer.

  2022cites this paper
• PTEN Expression Was Significantly Associated with PD-L1 Score but Not with EBV Infection in Gastric Cancer

  2022cites this paper
• Molecular pathways in periampullary cancer: An overview.

  2022cites this paper
• Flurbiprofen inhibits cell proliferation in thyroid cancer through interrupting HIP1R-induced endocytosis of PTEN

  2022cites this paper
• Follicular Growth Pattern Disease on Thyroid Fine-needle Aspiration Biopsy

  2022cites this paper
• Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View

  2022cites this paper
• Genomic and epigenomic profile of thyroid cancer.

  2022cites this paper
• Promoter Methylation of Tumor Suppressors in Thyroid Carcinoma: A Systematic Review

  2021cites this paper
• Epigenetic modification and BRAF gene mutation in thyroid carcinoma

  2021cites this paper
• The significant increase of miR-140-5P in papillary thyroid cancer samples

  2021cites this paper
• New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma.

  2021cites this paper
• Metabolic reprogramming and epigenetic modifications on the path to cancer

  2021cites this paper
• Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics

  2021cites this paper
• Translational Potential of Epigenetic-Based Markers on Fine-Needle Aspiration Thyroid Specimens

  2021cites this paper
• Emerging Biomarkers in Thyroid Practice and Research

  2021cites this paper
• Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy

  2021cites this paper
• Epigenetic Modifications in the Endocrine System Organs Cancer

  2020cites this paper
• Tumor Suppressors Having Oncogenic Functions: The Double Agents

  2020cites this paper
• Biological implications of PTEN upregulation and altered sodium/iodide symporter intracellular distribution in resveratrol-suppressed anaplastic thyroid cancer cells

  2020cites this paper
• Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis

  2020cites this paper
• Alterations of regulatory factors and DNA methylation pattern in thyroid cancer

  2020cites this paper
• Research Progress of DNA Methylation in Thyroid Cancer

  2020influential citation
• Diagnostic significance of DNA methylation of PTEN and DAPK in thyroid tumors

  2020cites this paper
• Abstract. PTEN inactivation is a frequent event in onco- genesis. Multiple regulatory mechanisms such as promoter hypermethylation, antisense regulation, histone modifications, targeting by microRNAs (miRNAs/miRs) and regulation by transcription factors have all been shown to affect the tumor suppre

  2020cites this paper
• Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer

  2020cites this paper
• PGPM_A_181520 235..245

  2019cites this paper
• The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities

  2019cites this paper
• Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

  2019cites this paper
• Identification and validation of mRNA 3′untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN

  2019cites this paper
• Title Radiation-Associated Small Cell Neuroendocrine Carcinoma of theThyroid : A Case Report with Molecular Analyses

  2019cites this paper
• Methylation of tumour suppressor genes associated with thyroid cancer

  2019cites this paper
• p53, PTEN Tumor Suppressor Gene Methylation in Thyroid Cancer

  2019influential citation
• Potential of epigenetic events in human thyroid cancer.

  2019cites this paper
• Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression

  2019cites this paper
• Precise Immunodetection of PTEN Protein in Human Neoplasia.

  2019cites this paper
• PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.

  2019cites this paper
• Personalized treatment options for thyroid cancer: current perspectives

  2019cites this paper
• PTEN in Hereditary and Sporadic Cancer.

  2019cites this paper
• E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer

  2019cites this paper
• THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER.

  2018cites this paper
• Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels

  2018cites this paper
• Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing

  2018influential citation
• Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets

  2018cites this paper
• The role of PTEN as a PI(3,4)P2 lipid phosphatase in Class I phosphoinositide 3-kinase signalling

  2018cites this paper
• Concurrent Papillary Thyroid Cancer and Medullary Thyroid Cancer

  2018cites this paper
• Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes

  2018cites this paper
• Genetic and epigenetic alteration in thyroid cancer: review article

  2018cites this paper
• Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches

  2017cites this paper
• The epigenetic landscape of differentiated thyroid cancer.

  2017cites this paper
• Epigenetic modulators of thyroid cancer.

  2017cites this paper
• Key signaling pathways in thyroid cancer.

  2017cites this paper
• Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer

  2017cites this paper
• Nueva generación de biomarcadores epigenéticos y transcriptómicos en el cáncer de tiroides bien diferenciado

  2017cites this paper
• Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?

  2017cites this paper
• Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.

  2017cites this paper
• Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer.

  2017cites this paper
• The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila

  2016cites this paper
• مروری بر متیلاسیون DNA و نقش آن در توموری شدن سلول های تیروئیدی

  2016cites this paper
• DNA methylation analysis for the diagnosis of thyroid nodules – a pilot study with reference to BRAFV600E mutation and cytopathology results

  2016cites this paper
• Epigenetic Control in Human Normal Follicular Thyroid Cells and in Thyroid Carcinoma

  2016cites this paper
• PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells

  2016cites this paper
• The Role of DNA Methylation in Cancer.

  2016cites this paper
• Potential Approaches to Chemotherapy of Thyroid Cancer in the Future

  2016cites this paper
• Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis

  2016cites this paper
• Molecular Alterations and Expression Dynamics in the Etiopathogenesis of Thyroid Cancer

  2016cites this paper
• EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression

  2015cites this paper
• Epigenetics of Thyroid Cancer

  2015cites this paper
• Thyroid Follicular Cell Neoplasms in Multistep Carcinogenesis

  2015cites this paper
• Epigenetic modifications in human thyroid cancer.

  2015cites this paper
• The management of thyroid nodules and cancer in the molecular era

  2015cites this paper
• PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas

  2015cites this paper
• Epigenetic Alterations in well-DifferentiatedThyroid Cancer

  2015cites this paper
• Epigenetic alterations in cancer and personalized cancer treatment.

  2015cites this paper
• Identification of biomarkers for diagnosis of thyroid cancer and exploration of their functional role in cancerdevelopment

  2015cites this paper
• PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma

  2015cites this paper
• PI3K/PTEN signaling in liver diseases

  2015cites this paper
• Classification and General Considerations of Thyroid Cancer

  2015cites this paper
• Epigenetic modifications in human thyroid cancer (Review)

  2015cites this paper
• Epigenetics Territory and Cancer

  2015cites this paper
• Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status

  2014cites this paper
• IMPORTANCE OF EPIGENETIC CHANGES IN THE THYROID CANCER INCIDENCE AND THEIR THERAPEUTIC APPLICATIONS (REVIEW ARTICLE)

  2014cites this paper
• PTEN expression in patients with carcinoma of the cervix and its association with p53, Ki-67 and CD31.

  2014cites this paper
• Importance of Epigenetic Changes in the Thyroid Cancer Incidence and Their Therapeutic Applications

  2014cites this paper
• Evolving approaches in managing radioactive iodine-refractory differentiated thyroid cancer.

  2014cites this paper
• Gene Methylation Associated with Differentiated Thyroid Cancer

  2014cites this paper
• An update on molecular biology of thyroid cancers.

  2014cites this paper
• Autophagy: A potential target for thyroid cancer therapy (Review).

  2014cites this paper
• Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.

  2014cites this paper
• NRAS Codon 61 Mutation Is Associated with Distant Metastasis in Patients with Follicular Thyroid Carcinoma

  2014cites this paper